NEW YORK (GenomeWeb) – Enterome Bioscience today said that it has signed an agreement with the Mayo Clinic to collaborate on the discovery and validation of microbiome-based tests for predicting response to medical nutritional intervention in obese and overweight patients.

The Mayo Clinic is currently conducting a study of the gut microbiome before and after dietary intervention. The aim of the research is commercialize a personalized nutrition test for obese patients with low-grade inflammation and certain metabolic risk factors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.